Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
WELL Health TechnologiesWHTCF 74 Cash-to-Debt is 0.16 as of Jun. 2026, which is 27% below its 10-year median of 0.22. GuruFocus rates WHTCF with a GF Score™ of 74/100 and a GF Value™ of $5.02 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 671 Healthcare Providers & Services companies, WELL Health Technologies ranks worse than 78.24% on this metric.
Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. WELL Health Technologies's cash to debt ratio for the quarter that ended in Jun. 2026 was 0.16.
If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, WELL Health Technologiescouldn't pay off its debt using the cash in hand for the quarter that ended in Jun. 2026.
The historical rank and industry rank for WELL Health Technologies's Cash-to-Debt or its related term are showing as below:
WHTCF'
s Cash-to-Debt Range Over the Past 10 Years
Min: 0.06 Med: 0.22 Max: No Debt
Current: 0.16
During the past 13 years, WELL Health Technologies's highest Cash to Debt Ratio was No Debt. The lowest was 0.06. And the median was 0.22.
WHTCF's Cash-to-Debt is ranked worse than 78.24% of 671
companies
in the Healthcare Providers & Services industry
Industry Median: 0.79
vs WHTCF: 0.16
WELL Health Technologies (OTCPK:WHTCF) Cash-to-Debt Explanation
If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.
WELL Health Technologies Cash-to-Debt Related Terms
WELL Health Technologies Cash-to-Debt Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
For the Medical Care Facilities subindustry, WELL Health Technologies's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
WELL Health Technologies Cash-to-Debt vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, WELL Health Technologies's Cash-to-Debt distribution charts can be found below:
* The bar in red indicates where WELL Health Technologies's Cash-to-Debt falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WELL Health Technologies (WHTCF) has a Cash-to-Debt of 0.16 as of Jun. 2026. This is 27% below median its historical median of 0.22. Over the past decade, WELL Health Technologies' Cash-to-Debt has ranged from 0.06 to 10,000.00. According to the industry distribution chart, WELL Health Technologies ranks #525 out of 671 companies in the Healthcare Providers & Services industry, placing it in the top 78.2%.
Is WELL Health Technologies' Cash-to-Debt too high?
WELL Health Technologies' current Cash-to-Debt of 0.16 is 27% below median its 10-year median of 0.22. Over the past 10 years, this metric has ranged from a low of 0.06 to a high of 10,000.00. The Healthcare Providers & Services industry median Cash-to-Debt is 0.79. WELL Health Technologies' value of 0.16 is 79.7% below this industry median. Based on the distribution chart, WELL Health Technologies ranks #525 out of 671 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, WELL Health Technologies has a GF Score™ of 74/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does WELL Health Technologies' Cash-to-Debt compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, WELL Health Technologies ranks #525 out of 671 companies for Cash-to-Debt. This places WELL Health Technologies in the lower half of its industry. The industry median Cash-to-Debt is 0.79. WELL Health Technologies' value of 0.16 is 79.7% below this benchmark. Historically, WELL Health Technologies' own Cash-to-Debt has ranged from 0.06 to 10,000.00 over the past decade. While the company's 10-year median is 0.22 vs. the industry median of 0.79, WELL Health Technologies has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash-to-Debt for a Healthcare Providers & Services company?
The median Cash-to-Debt among Healthcare Providers & Services companies is 0.79, based on 671 companies in the industry. Companies in the top quartile (top 25%) have a Cash-to-Debt significantly above this median, while those in the bottom quartile fall well below. However, Cash-to-Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. WELL Health Technologies's current Cash-to-Debt of 0.16 is 79.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash-to-Debt mean?
A high Cash-to-Debt can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median Cash-to-Debt is 0.79 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. WELL Health Technologies's current Cash-to-Debt is 0.16, which is 27% below median its own 10-year median of 0.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is WELL Health Technologies stock overvalued right now?
Based on GuruFocus' analysis, WELL Health Technologies (WHTCF) is currently considered Possible Value Trap. The stock's GF Value™ is $5.02, compared to a current price of $3.10 — trading 38.3% below its estimated fair value. The current Cash-to-Debt is 0.16, which is 27% below median its 10-year median of 0.22 and 79.7% below the Healthcare Providers & Services industry median of 0.79. WELL Health Technologies' overall GF Score™ is 74/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash-to-Debt calculated?
Cash-to-Debt is calculated from a company's financial statements. For WELL Health Technologies (WHTCF), the current Cash-to-Debt is 0.16 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is WELL Health Technologies (WHTCF) Overvalued in 2026?
Based on GuruFocus' analysis, WELL Health Technologies stock appears to be undervalued.
The current stock price of $3.10 is trading 38.3% below its estimated GF Value™ of $5.02.
GuruFocus considers WELL Health Technologies to be Possible Value Trap.
Key valuation signals for WHTCF:
Cash-to-Debt: 0.16 (27% below median its 10-year median of 0.22)
GF Value™: $5.02 vs. price of $3.10 (38.3% below fair value)
Industry Position: 79.7% below the Healthcare Providers & Services median (#525 of 671)
No single metric tells the full story. See the WHTCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
WELL Health Technologies Corp is a practitioner-focused digital healthcare company. It has seven reportable segments that are grouped into three key business units: Canadian Patient Services that includes Primary and Specialized MyHealth; WELL Health USA Patient Services, which derives maximum revenue, includes Primary Circle Medica, Primary WISP, Specialized CRH Medical, and Specialized Provider Staffing; SaaS and Technology Services provides digital health and infrastructure solutions for healthcare providers, including Electronic MedicalRecords (EMRs), patient engagement and eReferral solutions, AI-enabled applications, billing and practice management services, and cybersecurity protection and data privacy solutions; and HEALWELL: AI and data sciences and healthcare software offerings.
74GF Score
Get the complete analysis for WHTCF
Cash-to-Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WHTCF has been successfully added to your 
